Ecrf
Advertisement
The EnGeneIC Cancer Research Foundation (ECRF), established in 2007 by Dr. Jennifer MacDiarmid and Dr. Himanshu Brahmbhatt, focuses on innovative and personalized approaches to cancer treatment. With an emphasis on supporting clinical trials and scholarships for researchers in the field of low survival cancers, the foundation aims to reshape cancer therapy through tailored solutions rather than standardized methods.
After a six-year hiatus due to the pandemic, ECRF is reviving its celebrated black-tie events with the Celestial Ball scheduled for March 2026, celebrating its ongoing mission to combat cancer. The foundation's research efforts have led to groundbreaking techniques, including the development of the EnGeneIC Dream Vector for drug delivery, which minimizes the side effects associated with traditional chemotherapy.
Generated from the website
Also at this address
You might also like
Advertisement